Larry Blandford, PharmD

Pharma Insights
Economic Assessment of Novel Gene and Cellular Therapies: Beyond Traditional Modeling
04/17/2018
Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...
Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...
...
04/17/2018
Journal of Clinical Pathways
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
Pharma Insights
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
03/16/2020
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The...
03/16/2020
Journal of Clinical Pathways
Pharma Insights
The Clash: Treatment Advances and Value Measurements in Oncology
04/11/2017
Cancer has or will affect nearly every person at some point in their lives, either directly or indirectly. The fight against cancer is central to society; in recent years, treatment advances and prevention strategies...
Cancer has or will affect nearly every person at some point in their lives, either directly or indirectly. The fight against cancer is central to society; in recent years, treatment advances and prevention strategies...
Cancer...
04/11/2017
Journal of Clinical Pathways
Pharma Insights
Accreditation Explosion Among Top Specialty Pharmacy Trends
09/13/2018
As the health care delivery system continues its transition to a value-based reimbursement model, pharmacies face many of the same market pressures as other health care providers to improve patient outcomes and...
As the health care delivery system continues its transition to a value-based reimbursement model, pharmacies face many of the same market pressures as other health care providers to improve patient outcomes and...
As the...
09/13/2018
Journal of Clinical Pathways
Equivalars: Could They Bring Down the Cost of Rx Drugs?
Pharma Insights
Equivalars: Could They Bring Down the Cost of Rx Drugs?
04/21/2020
A recent announcement that new biotech start-up, EQRx plans to launch “equivalars,” alternatives to a number of currently patented costly drugs at far lower price points, introduces another disruptive solution trying...
A recent announcement that new biotech start-up, EQRx plans to launch “equivalars,” alternatives to a number of currently patented costly drugs at far lower price points, introduces another disruptive solution trying...
A...
04/21/2020
Journal of Clinical Pathways
Pharma Insights
What Does New Payer Research on Expected Biosimilar Management Mean to Others?
05/12/2017
Although the biosimilar era has officially launched, only one agent has entered the market as of April 2017. That would be Zarxio1, approved in March 2015 as a biosimilar for the market-leading granulocyte...
Although the biosimilar era has officially launched, only one agent has entered the market as of April 2017. That would be Zarxio1, approved in March 2015 as a biosimilar for the market-leading granulocyte...
...
05/12/2017
Journal of Clinical Pathways
Pharma Insights
Will Any Value Frameworks Gain Acceptance as an Informal Health Technology Assessment in the United States?
11/18/2018
In recent years, several value frameworks, including the Institute for Clinical and Economic Review, have emerged to help payers assess the value of new drugs. These frameworks highlight efforts to adopt some type of...
In recent years, several value frameworks, including the Institute for Clinical and Economic Review, have emerged to help payers assess the value of new drugs. These frameworks highlight efforts to adopt some type of...
In...
11/18/2018
Journal of Clinical Pathways
Journeying Through the Past, Present, and Future of Medicare Part D
Pharma Insights
Journeying Through the Past, Present, and Future of Medicare Part D
06/17/2020
This article explores the beginnings of Medicare Part D and the different dynamics driving current and future change for various stakeholders including the Centers for Medicare & Medicaid Services, plan sponsors,...
This article explores the beginnings of Medicare Part D and the different dynamics driving current and future change for various stakeholders including the Centers for Medicare & Medicaid Services, plan sponsors,...
This...
06/17/2020
Journal of Clinical Pathways
Pharma Insights
Are Formulary Exclusion Lists Aligned or Contrary to the Shift to Value-Base Care?
09/19/2017
The use of formulary exclusion lists continues to expand, with clear impacts to the perception and use of all related medications. Annual updates to these lists suggest a need for careful evaluation by benefit...
The use of formulary exclusion lists continues to expand, with clear impacts to the perception and use of all related medications. Annual updates to these lists suggest a need for careful evaluation by benefit...
The...
09/19/2017
Journal of Clinical Pathways
Pharma Insights
ACOs: Changing Health Care Cost and Quality to Be Accountable
12/13/2018
Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...
Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...
...
12/13/2018
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use